Chen, D.-Y.; Lin, C.-H.; Chen, H.-H.; Chen, Y.-M.; Tang, K.-T.
Mandatory Biological/Targeted Synthetic Disease-Modifying Antirheumatic Drugs Dose Reduction on Risk of Serious Infections in Patients with Rheumatoid Arthritis: A Nationwide Nested Case–Control Study. Biomedicines 2025, 13, 2891.
https://doi.org/10.3390/biomedicines13122891
AMA Style
Chen D-Y, Lin C-H, Chen H-H, Chen Y-M, Tang K-T.
Mandatory Biological/Targeted Synthetic Disease-Modifying Antirheumatic Drugs Dose Reduction on Risk of Serious Infections in Patients with Rheumatoid Arthritis: A Nationwide Nested Case–Control Study. Biomedicines. 2025; 13(12):2891.
https://doi.org/10.3390/biomedicines13122891
Chicago/Turabian Style
Chen, Der-Yuan, Ching-Heng Lin, Hsin-Hua Chen, Yi-Ming Chen, and Kuo-Tung Tang.
2025. "Mandatory Biological/Targeted Synthetic Disease-Modifying Antirheumatic Drugs Dose Reduction on Risk of Serious Infections in Patients with Rheumatoid Arthritis: A Nationwide Nested Case–Control Study" Biomedicines 13, no. 12: 2891.
https://doi.org/10.3390/biomedicines13122891
APA Style
Chen, D.-Y., Lin, C.-H., Chen, H.-H., Chen, Y.-M., & Tang, K.-T.
(2025). Mandatory Biological/Targeted Synthetic Disease-Modifying Antirheumatic Drugs Dose Reduction on Risk of Serious Infections in Patients with Rheumatoid Arthritis: A Nationwide Nested Case–Control Study. Biomedicines, 13(12), 2891.
https://doi.org/10.3390/biomedicines13122891
